About US
Contact us
-
AstraZeneca’s MedImmune completes licensing agreement with Allergan for MEDI2070British drugmaker AstraZeneca’s global biologics research and development arm MedImmune has completed a licensing agreement with Allergan for the global rights to IL-23 monoclonal antibody MEDI2070.2016/11/22
-
Eli Lilly secures conditional marketing authorisation for olaratumab injection with doxorubicinThe European Commission (EC) has granted conditional marketing authorisation for Eli Lilly and Company’s (LLY) olaratumab injection of 10mg/ml in combination with doxorubicin, to treat adults with adv2016/11/21
-
Report: Novel pipeline products to drive schizophrenia market growthThe schizophrenia market is projected to increase from $6.4bn in 2015 to $7.3bn by 2025 at a compound annual growth rate of 1.4%, according to a report by GlobalData. Titled 'PharmaPoint: Schizophren2016/11/21
-
M&As this week: CiToxLAB, Sichuan Kelun PharmaFrench-based pre-clinical services providerCiToxLAB Grouphas announced that it has acquired a pre-clinical contract research company known as AccelLAB. "The acquisition is expected to foster the acqu2016/11/18
-
Deals this week: Incyte Corporation, Orexigen Therapeutics Ireland, Mitsubishi Tanabe Pharma CorporationUS-based biopharmaceutical companyIncyte Corporationhas entered a distribution agreement for the commercialisation of its drug named Iclusig (ponatinib) in Greece with GENESIS Pharma. The agreement w2016/11/18
-
Haiti launches cholera vaccination campaignHaiti has launched an emergency cholera vaccination campaign, under which more than 800,000 affected by Hurricane Matthew last month will be vaccinated. After the category-four storm devastated south2016/11/17
-
Teva receives approval for generic Tribenzor in USTeva Pharmaceutical Industries has secured approval for generic Tribenzor(olmesartan medoxomil, amlodipine and hydrochlorothiazide) tablets in the US and is in the last stages of launch preparation.2016/11/17
-
University of Adelaide researchers test drug that promises to prevent pre-term birthResearchers at the University of Adelaide have conducted a successful drug test that shows early promises of preventing pre-term birth. This success will help to understand the inflammatory mechanism2016/11/16
-
NICE recommends treatment with 60mg of ticagrelor in post-heart attack patientsAstraZeneca has announced that National Institute of Health and Care Excellence (NICE) has published a Final Appraisal Determination (FAD) recommending 60mg of ticagrelor with aspirin for anti-clottin2016/11/16
-
Brexit battle heats up over winning EMA from LondonA long list of EU countries would love to behometo the European Medicines Agency (EMA) post-Brexit--France, Italy, Denmark, Sweden, Hungary and more. But the U.K. is not going to let it go without put2016/11/15